A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins.

Siska Cochran1, Cai Ping Li, Vito Ferro

  • 1Drug Design Group, Progen Pharmaceuticals Ltd, Darra, QLD, Australia.

Glycoconjugate Journal
|November 27, 2008
PubMed
Summary

A new surface plasmon resonance assay accurately measures heparin-binding protein affinity for various ligands. This method is ideal for rapid screening of potential drug discovery candidates.

Related Concept Videos